Latest Articles

AI and ML are changing chromatography. Hear from an expert about the hype, the challenges and the opportunities seen today.

Where do the greatest opportunities for collaboration across life sciences disciplines lie today – and what’s needed to unlock them? We asked the experts.

Explore the advantages of virtual screening in drug discovery, offering rapid evaluation and cost savings over traditional methods.

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

A high-throughput proteomics study of newborn dried blood spots uncovered a three-protein biomarker panel that distinguished preterm infants who later died of SIDS from matched controls, highlighting biological differences in preterm SIDS cases.

UK Biobank’s expansion of Olink proteomics from 50,000 to 500,000 participants marks a major step toward true population-scale multi-omics. Deputy Chief Scientist Dr. Adam Lewandowski discusses the challenges of releasing this high-dimensional data.

Explore the world of X-ray spectroscopy, a key tool for unveiling atomic structures and elemental compositions across diverse fields.

A definitive guide to proteomics definitions, mass spectrometry terminology, and key concepts in quantitative proteomics for life science researchers and lab scientists.

Middle-down proteomics addresses the limitations of conventional bottom-up approaches by providing deeper insight into proteoform analysis.

A detailed examination of top-down proteomics and its critical role in comprehensive proteoform identification using advanced mass spectrometry techniques.